Sangamo Therapeutics Stock Slumps After Pfizer Terminates Hemophilia A Gene Therapy Partnership

December 19, 20250

Sangamo Therapeutics’ (SGMO) shares were sinking intraday Tuesday after the company said its partner

Leave a Reply

Your email address will not be published.